表紙
市場調查報告書
商品編碼
1069457

抗體藥物複合體的全球市場:產業分析,規模,佔有率,成長,趨勢,預測(2022年∼2028年)

Global Antibody Drug Conjugates Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

出版日期: | 出版商: Value Market Research | 英文 100 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球抗體藥物複合體市場今後數年預計將大幅成長。

本報告提供全球抗體藥物複合體市場調查,提供市場概要,市場的推動因素與阻礙因素的分析,市場課題與機會,COVID-19影響,各類型·各用途·各地區的市場分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 抗體藥物複合體 - 產業分析

  • 簡介 - 市場動態
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 產業趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主清單
  • 行銷流通管道

第5章 COVID-19發生的影響分析

  • COVID-19發生的影響分析
  • COVID-19影響分析:生產,進口,出口,各需求
  • 市場:COVID-19以前 vs COVID-19以後
  • 冠狀病毒(COVID-19)流行的影響估計
  • COVID-19:微觀及宏觀因素分析

第6章 全球抗體藥物複合體市場分析:各類型

  • 概要:各類型
  • 實際成果資料與預測資料
  • 分析:各類型
  • 單株抗體:各地區
  • 連接試劑:各地區
  • 藥物/毒素:各地區
  • 其他:各地區

第7章 全球抗體藥物複合體市場分析:各用途

  • 概要:各用途
  • 實際成果資料與預測資料
  • 分析:各用途
  • 血液癌症:各地區
  • 乳癌:各地區
  • 卵巢癌症:各地區
  • 肺癌症:各地區
  • 腦瘤:各地區
  • 其他:各地區

第8章 全球抗體藥物複合體市場分析:各地區

  • 地區預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第9章 抗體藥物複合體企業的競爭情形

  • 抗體藥物複合體市場競爭
  • 夥伴關係/合作/契約
  • 合併·收購
  • 新產品的銷售
  • 其他的開發

第10章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • F. Hoffman-La Roche Ltd.
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Seattle Genetics Inc.
  • Genentech Inc.
  • Immunogen Inc.
  • Immunomedics Inc.
  • Progenics Pharmaceuticals Inc.
  • Bayer Healthcare Pharmaceuticals

附註:企業簡介中財務資訊與最近的發展有賴於得到的情報,故可能不包含未公開財務資訊的私人企業。

目錄
Product Code: VMR11210482

Value Market Research deeply researched the Global Antibody Drug Conjugates Market to foresee a significant growth in the industry over the upcoming years. The global antibody drug conjugates market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global antibody drug conjugates market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this antibody drug conjugates market.

The next sections of the antibody drug conjugates market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Types

Monoclonal Antibodies

Linker

Drug/Toxin

Others

By Application

Leukemia

Prostate Cancer

Kidney Cancer

Pancreas Cancer

Ovary Cancer

Glioblastoma

Lung Cancer

Colon Cancer

Breast Cancer

Skin Cancer

Solid Tumors

Multiple Myeloma

Lymphoma

Other Cancers

By Product

Adcertis

Kadcyla

Others

By Technology

Immunogen Technology

Seattle Genetics Technology

Immunomedics Technology

Others

By End-User

Hospitals

Specialized Cancer Centers

Academic Research Institutes

Biotechnology Companies

Biopharmaceutical Companies

Others

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ANTIBODY DRUG CONJUGATES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Types
    • 3.7.2 By Application
    • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY TYPES

  • 6.1 Overview by Types
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Types
  • 6.4 Monoclonal Antibodies Market by Regions
  • 6.6 Linker Market by Regions
  • 6.5 Drug/Toxin Market by Regions
  • 6.7 Others Market by Regions

7 . GLOBAL ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Blood Cancer Market by Regions
  • 7.5 Breast Cancer Market by Regions
  • 7.6 Ovarian Cancer Market by Regions
  • 7.7 Lung Cancer Market by Regions
  • 7.8 Brain Tumour Market by Regions
  • 7.9 Others Market by Regions

8 . GLOBAL ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview, Historic and Forecast Data
    • 8.3.2. North America By Segment
    • 8.3.3. North America By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview, Historic and Forecast Data
    • 8.4.2. Europe by Segment
    • 8.4.3. Europe by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview, Historic and Forecast Data
    • 8.5.2. Asia Pacific by Segment
    • 8.5.3. Asia Pacific by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview, Historic and Forecast Data
    • 8.6.2. Latin America by Segment
    • 8.6.3. Latin America by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview, Historic and Forecast Data
    • 8.7.2. Middle East & Africa by Segment
    • 8.7.3. Middle East & Africa by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE ANTIBODY DRUG CONJUGATES COMPANIES

  • 9.1. Antibody Drug Conjugates Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ANTIBODY DRUG CONJUGATES INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. F. Hoffman-La Roche Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Novartis AG
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Takeda Pharmaceutical Company Limited
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Pfizer Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Seattle Genetics Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Genentech Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Immunogen Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Immunomedics Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Progenics Pharmaceuticals Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Bayer Healthcare Pharmaceuticals
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Types (USD MN)
  • Monoclonal Antibodies Market by Geography (USD MN)
  • Linker Market by Geography (USD MN)
  • Drug/Toxin Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Blood Cancer Market by Geography (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Ovarian Cancer Market by Geography (USD MN)
  • Lung Cancer Market by Geography (USD MN)
  • Brain Tumour Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Antibody Drug Conjugates Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Antibody Drug Conjugates Report
  • Market Research Process
  • Market Research Methodology
  • Global Antibody Drug Conjugates Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Types
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Types (USD MN)
  • Monoclonal Antibodies Market by Geography (USD MN)
  • Linker Market by Geography (USD MN)
  • Drug/Toxin Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Blood Cancer Market by Geography (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Ovarian Cancer Market by Geography (USD MN)
  • Lung Cancer Market by Geography (USD MN)
  • Brain Tumour Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.